Skip to main content
OpenTrials

Clinical trial condition

Extensive-stage Small-cell Lung Cancer

Explore clinical trials studying Extensive-stage Small-cell Lung Cancer. Study availability and eligibility vary by location and protocol.

36 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Extensive-stage Small-cell Lung Cancer trial results

Active, Not Recruiting

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

NCT06449209

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Hematology Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

NCT05280470

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • The Cancer Specialists, Llc Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

NCT06211036

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Infirmary Cancer Center Mobile, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
View all 219 locations
View Trial Details
Active, Not Recruiting

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

NCT05796089

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Westmead Hospital Sydney, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia
View Trial Details
Active, Not Recruiting

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

NCT06008353

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • Oncologia D'Or Unidade Esperança Pernambuco Recife, Pernambuco, Brazil
  • Instituto D'Or de Pesquisa e Ensino RJ Rio de Janeiro, Brazil
  • BP - A Beneficência Portuguesa de São Paulo São Paulo, Brazil
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details

Related conditions